| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 12.550 | 40.914 | 804.641 | 5.396.969 | 1.928.795 | 168.215 | 6.413 |
| Total Income - EUR | - | - | - | 12.550 | 40.925 | 804.643 | 5.951.226 | 2.476.390 | 208.443 | 15.885 |
| Total Expenses - EUR | - | - | - | 20.373 | 25.752 | 776.918 | 2.955.817 | 1.605.321 | 394.367 | 24.668 |
| Gross Profit/Loss - EUR | - | - | - | -7.823 | 15.172 | 27.725 | 2.995.409 | 871.069 | -185.924 | -8.783 |
| Net Profit/Loss - EUR | - | - | - | -8.200 | 14.148 | 19.678 | 2.629.560 | 829.254 | -185.924 | -8.783 |
| Employees | - | - | - | 0 | 1 | 19 | 34 | 24 | 9 | 1 |
Check the financial reports for the company - Citobiomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 17.813 | 14.677 | 286.016 | 274.048 | 292.059 | 85.558 | 68.457 |
| Current Assets | - | - | - | 7.733 | 9.311 | 322.921 | 3.084.615 | 1.462.788 | 1.123.243 | 1.109.570 |
| Inventories | - | - | - | 6.364 | 8.270 | 24.450 | 57.265 | 2.759 | 0 | 0 |
| Receivables | - | - | - | 720 | 796 | 233.677 | 2.206.733 | 1.429.882 | 1.113.993 | 1.108.552 |
| Cash | - | - | - | 0 | 245 | 64.794 | 820.617 | 30.148 | 9.250 | 1.019 |
| Shareholders Funds | - | - | - | -8.114 | 6.191 | 27.737 | 2.631.986 | 831.688 | 643.242 | 630.864 |
| Social Capital | - | - | - | 86 | 84 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | 38.918 | 22.848 | 586.757 | 732.856 | 926.452 | 565.559 | 547.163 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Citobiomed S.r.l.